Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool (MS Predictor)

NCT07704294 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT07704294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07704294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool (MS Predictor)
Lead sponsor
King's College London
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 1, 2027
Enrollment
180 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, myelin oligodendrocyte glycoprotein (mog)-antibody related disorders, neuromyelitis optica spectrum disorder, optic neuritis, sarcoid